Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 28;50(1):254.
doi: 10.1186/s13052-024-01824-5.

Allergic rhinitis management: a Delphi Consensus promoted by the Italian Society of Pediatric Allergy and Immunology (SIAIP)

Michele Miraglia Del Giudice  1 , Gian Luigi Marseglia  2   3 , Diego G Peroni  4 , Anna Maria Zicari  5 , Giulio Dinardo  1 , Giorgio Ciprandi  6
Affiliations

Allergic rhinitis management: a Delphi Consensus promoted by the Italian Society of Pediatric Allergy and Immunology (SIAIP)

Michele Miraglia Del Giudice et al. Ital J Pediatr. .

Abstract

Allergic rhinitis (AR) is the most frequent IgE-mediated disease, mainly in children and adolescents. Management of AR in the pediatric age may be heterogeneous, and the available guidelines do not adequately consider this issue. As a result, the Italian Society of Pediatric Allergy and Immunology (SIAIP) promoted a Delphi Consensus to define and evaluate the most relevant aspects of AR management in the pediatric setting in Italy. A qualified board of experts prepared a list of statements that a panel of Italian experts voted on using a web platform. Forty-two pediatricians participated. The results showed that all statements had consensus (> 80% of scores 4 + 5). In particular, there was awareness that AR is a type 2 inflammatory disease requiring adequate treatment. Topical drugs should be preferred, as they are better with cycles. Combined antihistamine/corticosteroid is also considered effective and safe in adolescents. In conclusion, AR deserves adequate attention and care. Current medications are safe and effective; treatment should be addressed to dampen type 2 inflammation and relieve complaints.

Keywords: Allergic rhinitis; Clinical practice; Delphi Consensus; Management; SIAIP.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Distribution of agreement score for Statements 1–9
Fig. 2
Fig. 2
Distribution of agreement score for Statements 10–18
Fig. 3
Fig. 3
Distribution of agreement score for Statements 19–22
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Zicari AM, Indinnimeo L, De Castro G, Incorvaia C, Frati F, Dell’Albani I, et al. A survey on features of allergic rhinitis in children. Curr Med Res Opin. 2013;29:415–20. - PubMed
    1. Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–8. - PubMed
    1. Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised Edition 2017; First Edition 2007). Clin Exp Allergy. 2017;47(7):856–89. - PubMed
    1. Dykewicz MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020;146(4):721–67. - PubMed
    1. Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, Kawauchi H, et al. Japanese guidelines for allergic rhinitis 2020. Allergol Int. 2020;69(3):331–45. - PubMed

Substances

LinkOut - more resources